Eton Pharmaceuticals, Inc. (ETON) Financials

ETON Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 31.7 million 16.3 million
2023-09-30 31.5 million 14.6 million
2023-06-30 30.9 million 14.2 million
2023-03-31 23.9 million 12.7 million

ETON Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 -388000 750000
2023-09-30 873000 730000
2023-06-30 7.1 million 785000
2023-03-31 -1.5 million 872000

ETON Net Income

No data available :(

ETON Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 - - 22000
2023-09-30 22.1 million - 44000
2023-06-30 21.6 million - 66000
2023-03-31 14.7 million 5.1 million 86000

ETON Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 25.7 million
2023-09-30 25.7 million
2023-06-30 26.0 million
2023-03-31 25.5 million

ETON Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 - 1.0 million 4.6 million -
2023-09-30 - 615000 4.3 million -
2023-06-30 - 1.1 million 4.7 million -
2023-03-31 - 535000 5.3 million -

ETON Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 7.3 million 3.7 million
2023-09-30 7.0 million 2.6 million
2023-06-30 12.0 million 2.3 million
2023-03-31 5.3 million 2.0 million

ETON

Price: $3.45

52 week price:
2.42
5.81

Earnings Per Share: -0.04 USD

P/E Ratio: -449

Exchange: NGM

Sector: Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Volume: 36257

Market Capitalization: 92.2 million

Links: